Endometrial brush biopsy for the diagnosis of endometrial cancer

Giuseppe Del Priore, Renee Williams, Carrie B. Harbatkin, Livia S. Wan, Khush Mittal, Grace C H Yang

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate a new technique for processing endometrial cytology for the diagnosis and exclusion of endometrial cancer. STUDY DESIGN: All women at risk for endometrial cancer with clinical indications for endometrial biopsy were evaluated by endometrial brush biopsy (Tao Brush, Cook OB-GYN, Bloomington, Indiana) and Pipelle (Cooper Surgical, Shelton, Connecticut) endometrial biopsies during one office visit. Patients were followed longitudinally for the development of endometrial cancer or until undergoing dilatation and curettage or hysterectomy. All comparisons were analyzed using the X 2 or t test. RESULTS: One hundred one women (mean age, 58; range, 35-86) had endometrial biopsies performed. Median follow-up was > 21 months (range, 3-29). Twenty-two had cancer or atypia, while the remaining had benign diagnoses. When correlated with the final diagnosis, the Tao Brush had 95.5% sensitivity and the Pipelle, 86% sensitivity. Both devices had 100% specificity, positive predictive value of 100% and negative predictive value of 98%. When the results of the two biopsy devices are considered together, the positive and negative predictive value for detecting or excluding endometrial cancer was 100%. Based on 1998 Medicare reimbursements, a simultaneous second office biopsy using the Tao brush could save approximately $67 per case as compared to a sonohistogram and much more when compared to dilatation and curettage. CONCLUSION: Endometrial cancer can be reliably detected and excluded using these two distinct office biopsy devices simultaneously during one office visit. In patients with an indication for endometrial biopsy, no further diagnostic test may be necessary to exclude or diagnose endometrial cancer or atypia.

Original languageEnglish (US)
Pages (from-to)439-443
Number of pages5
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume46
Issue number5
StatePublished - May 2001
Externally publishedYes

Fingerprint

Endometrial Neoplasms
Biopsy
Office Visits
Dilatation and Curettage
Equipment and Supplies
Medicare
Hysterectomy
Routine Diagnostic Tests
Cell Biology
Neoplasms

Keywords

  • Apparatus and instruments
  • Biopsy
  • Endometrial brush biopsy
  • Endometrial neoplasms

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Del Priore, G., Williams, R., Harbatkin, C. B., Wan, L. S., Mittal, K., & Yang, G. C. H. (2001). Endometrial brush biopsy for the diagnosis of endometrial cancer. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 46(5), 439-443.

Endometrial brush biopsy for the diagnosis of endometrial cancer. / Del Priore, Giuseppe; Williams, Renee; Harbatkin, Carrie B.; Wan, Livia S.; Mittal, Khush; Yang, Grace C H.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 46, No. 5, 05.2001, p. 439-443.

Research output: Contribution to journalArticle

Del Priore, G, Williams, R, Harbatkin, CB, Wan, LS, Mittal, K & Yang, GCH 2001, 'Endometrial brush biopsy for the diagnosis of endometrial cancer', Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 46, no. 5, pp. 439-443.
Del Priore G, Williams R, Harbatkin CB, Wan LS, Mittal K, Yang GCH. Endometrial brush biopsy for the diagnosis of endometrial cancer. Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 2001 May;46(5):439-443.
Del Priore, Giuseppe ; Williams, Renee ; Harbatkin, Carrie B. ; Wan, Livia S. ; Mittal, Khush ; Yang, Grace C H. / Endometrial brush biopsy for the diagnosis of endometrial cancer. In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 2001 ; Vol. 46, No. 5. pp. 439-443.
@article{7dab0991da1f40b38e7abe42c543621a,
title = "Endometrial brush biopsy for the diagnosis of endometrial cancer",
abstract = "OBJECTIVE: To evaluate a new technique for processing endometrial cytology for the diagnosis and exclusion of endometrial cancer. STUDY DESIGN: All women at risk for endometrial cancer with clinical indications for endometrial biopsy were evaluated by endometrial brush biopsy (Tao Brush, Cook OB-GYN, Bloomington, Indiana) and Pipelle (Cooper Surgical, Shelton, Connecticut) endometrial biopsies during one office visit. Patients were followed longitudinally for the development of endometrial cancer or until undergoing dilatation and curettage or hysterectomy. All comparisons were analyzed using the X 2 or t test. RESULTS: One hundred one women (mean age, 58; range, 35-86) had endometrial biopsies performed. Median follow-up was > 21 months (range, 3-29). Twenty-two had cancer or atypia, while the remaining had benign diagnoses. When correlated with the final diagnosis, the Tao Brush had 95.5{\%} sensitivity and the Pipelle, 86{\%} sensitivity. Both devices had 100{\%} specificity, positive predictive value of 100{\%} and negative predictive value of 98{\%}. When the results of the two biopsy devices are considered together, the positive and negative predictive value for detecting or excluding endometrial cancer was 100{\%}. Based on 1998 Medicare reimbursements, a simultaneous second office biopsy using the Tao brush could save approximately $67 per case as compared to a sonohistogram and much more when compared to dilatation and curettage. CONCLUSION: Endometrial cancer can be reliably detected and excluded using these two distinct office biopsy devices simultaneously during one office visit. In patients with an indication for endometrial biopsy, no further diagnostic test may be necessary to exclude or diagnose endometrial cancer or atypia.",
keywords = "Apparatus and instruments, Biopsy, Endometrial brush biopsy, Endometrial neoplasms",
author = "{Del Priore}, Giuseppe and Renee Williams and Harbatkin, {Carrie B.} and Wan, {Livia S.} and Khush Mittal and Yang, {Grace C H}",
year = "2001",
month = "5",
language = "English (US)",
volume = "46",
pages = "439--443",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "5",

}

TY - JOUR

T1 - Endometrial brush biopsy for the diagnosis of endometrial cancer

AU - Del Priore, Giuseppe

AU - Williams, Renee

AU - Harbatkin, Carrie B.

AU - Wan, Livia S.

AU - Mittal, Khush

AU - Yang, Grace C H

PY - 2001/5

Y1 - 2001/5

N2 - OBJECTIVE: To evaluate a new technique for processing endometrial cytology for the diagnosis and exclusion of endometrial cancer. STUDY DESIGN: All women at risk for endometrial cancer with clinical indications for endometrial biopsy were evaluated by endometrial brush biopsy (Tao Brush, Cook OB-GYN, Bloomington, Indiana) and Pipelle (Cooper Surgical, Shelton, Connecticut) endometrial biopsies during one office visit. Patients were followed longitudinally for the development of endometrial cancer or until undergoing dilatation and curettage or hysterectomy. All comparisons were analyzed using the X 2 or t test. RESULTS: One hundred one women (mean age, 58; range, 35-86) had endometrial biopsies performed. Median follow-up was > 21 months (range, 3-29). Twenty-two had cancer or atypia, while the remaining had benign diagnoses. When correlated with the final diagnosis, the Tao Brush had 95.5% sensitivity and the Pipelle, 86% sensitivity. Both devices had 100% specificity, positive predictive value of 100% and negative predictive value of 98%. When the results of the two biopsy devices are considered together, the positive and negative predictive value for detecting or excluding endometrial cancer was 100%. Based on 1998 Medicare reimbursements, a simultaneous second office biopsy using the Tao brush could save approximately $67 per case as compared to a sonohistogram and much more when compared to dilatation and curettage. CONCLUSION: Endometrial cancer can be reliably detected and excluded using these two distinct office biopsy devices simultaneously during one office visit. In patients with an indication for endometrial biopsy, no further diagnostic test may be necessary to exclude or diagnose endometrial cancer or atypia.

AB - OBJECTIVE: To evaluate a new technique for processing endometrial cytology for the diagnosis and exclusion of endometrial cancer. STUDY DESIGN: All women at risk for endometrial cancer with clinical indications for endometrial biopsy were evaluated by endometrial brush biopsy (Tao Brush, Cook OB-GYN, Bloomington, Indiana) and Pipelle (Cooper Surgical, Shelton, Connecticut) endometrial biopsies during one office visit. Patients were followed longitudinally for the development of endometrial cancer or until undergoing dilatation and curettage or hysterectomy. All comparisons were analyzed using the X 2 or t test. RESULTS: One hundred one women (mean age, 58; range, 35-86) had endometrial biopsies performed. Median follow-up was > 21 months (range, 3-29). Twenty-two had cancer or atypia, while the remaining had benign diagnoses. When correlated with the final diagnosis, the Tao Brush had 95.5% sensitivity and the Pipelle, 86% sensitivity. Both devices had 100% specificity, positive predictive value of 100% and negative predictive value of 98%. When the results of the two biopsy devices are considered together, the positive and negative predictive value for detecting or excluding endometrial cancer was 100%. Based on 1998 Medicare reimbursements, a simultaneous second office biopsy using the Tao brush could save approximately $67 per case as compared to a sonohistogram and much more when compared to dilatation and curettage. CONCLUSION: Endometrial cancer can be reliably detected and excluded using these two distinct office biopsy devices simultaneously during one office visit. In patients with an indication for endometrial biopsy, no further diagnostic test may be necessary to exclude or diagnose endometrial cancer or atypia.

KW - Apparatus and instruments

KW - Biopsy

KW - Endometrial brush biopsy

KW - Endometrial neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0035018712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035018712&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 439

EP - 443

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 5

ER -